0001437749-20-020635.txt : 20201001
0001437749-20-020635.hdr.sgml : 20201001
20201001202921
ACCESSION NUMBER: 0001437749-20-020635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200901
FILED AS OF DATE: 20201001
DATE AS OF CHANGE: 20201001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hollingsworth Jane H
CENTRAL INDEX KEY: 0001297141
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 201217811
MAIL ADDRESS:
STREET 1: DIFFUSION PHARMACEUTICALS INC.
STREET 2: 1317 CARLTON AVENUE, SUITE 200
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-09-01
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001297141
Hollingsworth Jane H
1317 CARLTON AVE
SUITE 200
CHARLOTTESVILLE
VA
22902
1
Stock Option (Right to Buy)
0.91
2020-09-01
4
A
0
67400
0
A
2030-09-01
Common Stock
67400
67400
D
Restricted Stock Unit
2020-09-01
4
A
0
54900
0
A
Common Stock
54900
54900
D
1. The shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning September 30, 2020.
2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
3. The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) quarterly installments on the last calendar day of each quarter over an 18-month period beginning on March 1, 2022.
/s/ William R. Elder, as attorney-in-fact for the Reporting Person
2020-10-01